The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
Telehealth company Hims & Hers is being called out over its Super Bowl ad going after Big Pharma and popular weight-loss ...
Erectile dysfunction (ED) is a common issue that affects millions of men, leading to a decline in quality of life and ...
Hims & Hers is under scrutiny for promoting ... depending on the specific drug and compounding process, as compounded medications are not subject to the same rigorous FDA regulations as ...